Palmer Knight Co Has $525,000 Stock Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

Palmer Knight Co boosted its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 3.5% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 997 shares of the healthcare conglomerate’s stock after purchasing an additional 34 shares during the quarter. Palmer Knight Co’s holdings in UnitedHealth Group were worth $525,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also bought and sold shares of UNH. Bray Capital Advisors grew its holdings in UnitedHealth Group by 0.5% during the 3rd quarter. Bray Capital Advisors now owns 9,616 shares of the healthcare conglomerate’s stock worth $4,848,000 after acquiring an additional 50 shares during the last quarter. Sterling Investment Counsel LLC grew its stake in shares of UnitedHealth Group by 2.9% in the 3rd quarter. Sterling Investment Counsel LLC now owns 3,237 shares of the healthcare conglomerate’s stock worth $1,632,000 after acquiring an additional 92 shares in the last quarter. Ballentine Partners LLC grew its position in UnitedHealth Group by 6.6% during the third quarter. Ballentine Partners LLC now owns 18,354 shares of the healthcare conglomerate’s stock valued at $9,254,000 after buying an additional 1,139 shares during the period. KRS Capital Management LLC grew its position in UnitedHealth Group by 3.7% during the third quarter. KRS Capital Management LLC now owns 2,557 shares of the healthcare conglomerate’s stock valued at $1,289,000 after buying an additional 92 shares during the period. Finally, TFG Advisers LLC boosted its position in UnitedHealth Group by 2.9% during the third quarter. TFG Advisers LLC now owns 8,591 shares of the healthcare conglomerate’s stock worth $4,331,000 after purchasing an additional 241 shares during the period. Institutional investors and hedge funds own 87.86% of the company’s stock.

Insider Buying and Selling

In related news, EVP Erin Mcsweeney sold 1,236 shares of the company’s stock in a transaction that occurred on Friday, March 8th. The stock was sold at an average price of $483.48, for a total value of $597,581.28. Following the sale, the executive vice president now owns 9,364 shares in the company, valued at $4,527,306.72. The sale was disclosed in a legal filing with the SEC, which is available through this link. In other news, CAO Thomas E. Roos sold 858 shares of the stock in a transaction that occurred on Friday, February 23rd. The stock was sold at an average price of $525.79, for a total transaction of $451,127.82. Following the transaction, the chief accounting officer now owns 32,289 shares in the company, valued at approximately $16,977,233.31. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Also, EVP Erin Mcsweeney sold 1,236 shares of the stock in a transaction on Friday, March 8th. The shares were sold at an average price of $483.48, for a total value of $597,581.28. Following the completion of the transaction, the executive vice president now directly owns 9,364 shares of the company’s stock, valued at $4,527,306.72. The disclosure for this sale can be found here. Corporate insiders own 0.35% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of brokerages have recently issued reports on UNH. TD Cowen lowered their price target on shares of UnitedHealth Group from $607.00 to $546.00 and set a “buy” rating on the stock in a report on Wednesday, April 10th. Erste Group Bank reaffirmed a “hold” rating on shares of UnitedHealth Group in a research note on Wednesday, March 13th. Piper Sandler increased their price target on shares of UnitedHealth Group from $566.00 to $571.00 and gave the company an “overweight” rating in a research report on Wednesday, April 17th. Barclays raised their target price on shares of UnitedHealth Group from $534.00 to $560.00 and gave the stock an “overweight” rating in a report on Wednesday, April 17th. Finally, Royal Bank of Canada cut their target price on shares of UnitedHealth Group from $596.00 to $555.00 and set an “outperform” rating on the stock in a report on Wednesday, April 17th. Four equities research analysts have rated the stock with a hold rating and fifteen have given a buy rating to the stock. Based on data from MarketBeat, UnitedHealth Group has a consensus rating of “Moderate Buy” and a consensus target price of $570.05.

UnitedHealth Group Stock Performance

Shares of NYSE:UNH traded down $4.78 during mid-day trading on Monday, reaching $490.57. 781,586 shares of the company traded hands, compared to its average volume of 4,462,439. The company’s 50 day moving average price is $485.84 and its 200-day moving average price is $514.07. The company has a debt-to-equity ratio of 0.69, a current ratio of 0.85 and a quick ratio of 0.79. UnitedHealth Group Incorporated has a 52 week low of $436.38 and a 52 week high of $554.70. The firm has a market cap of $451.36 billion, a PE ratio of 30.02, a PEG ratio of 1.43 and a beta of 0.54.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings results on Tuesday, April 16th. The healthcare conglomerate reported $6.91 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $6.63 by $0.28. UnitedHealth Group had a return on equity of 26.50% and a net margin of 4.05%. The business had revenue of $99.80 billion for the quarter, compared to the consensus estimate of $99.23 billion. During the same quarter in the prior year, the company earned $6.26 EPS. The business’s revenue was up 8.6% compared to the same quarter last year. On average, equities analysts expect that UnitedHealth Group Incorporated will post 27.61 EPS for the current fiscal year.

UnitedHealth Group Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Tuesday, March 19th. Shareholders of record on Monday, March 11th were paid a $1.88 dividend. This represents a $7.52 dividend on an annualized basis and a yield of 1.53%. The ex-dividend date of this dividend was Friday, March 8th. UnitedHealth Group’s dividend payout ratio (DPR) is presently 45.97%.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.